Proposed classification of pseudomyxoma peritonei: Influence of signet ring cells on survival

American Surgeon

Volumn 79, Issue 11, 2013, Pages 1171-1176

  Shetty, Shreya ^a   Natarajan, Bala ^a   Thomas, Peter ^a   Govindarajan, Venkatesh ^a   Sharma, Poonam ^a   Loggie, Brian ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CELL SURVIVAL; CELLS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; EPITHELIUM; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM PSEUDOMYXOMA; REPRODUCIBILITY; SEX DIFFERENCE; SIGNET RING CELL; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADULT; APPENDICEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84886661938     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008;34: 196-201.
2. Szych C, Staebler A, Connolly DC, et al. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 1999;154: 1849-55.
3. Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994;18: 591-603.
4. Pai RK, Beck AH, Norton JA, Longacre TA. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol 2009; 33: 1425-39.
5. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med 2010;134: 864-70.
6. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to 'pseudomyxoma peritonei.' Am J Surg Pathol 1995; 19: 1390-408.
7. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92: 85-91.
8. Bradley RF, Stewart JH IV, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30: 551-9.
9. Gopalan V, Smith RA, Ho YH, Lam AK. Signet-ring cell carcinoma of colorectum - current perspectives and molecular biology. Int J Colorectal Dis 2011;26: 127-33.
10. McGory ML, Maggard MA, Kang H, et al. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005; 48: 2264-71.
11. Mizushima T, Nomura M, Fujii M, et al. Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival. Surg Today 2010;40: 234-8.
12. Chew MH, Yeo SA, Ng ZP, et al. Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers. Int J Colorectal Dis 2010;25: 1221-9.
13. Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 2006;19: 59-68.
14. Wachtel MS, Haynes AL III, Griswold JA. Signet ring, high grade, and undifferentiated colorectal adenocarcinomas differ. J Surg Res 2010;163: 250-6.
15. Sasaki S, Masaki T, Umetani N, et al. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. J Clin Oncol 1998;28: 202-6.
16. Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System, 4th ed. International Agency for Research on Cancer (IARC) (UN). WHO 2010.
17. Maheshwari V, Tsung A, Lin Y, et al. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Ann Surg Oncol 2006;13: 1610-6.
18. Guo AT, Wei LX, Song X. Histologic classification and prognostic implication of pseudomyxoma peritonei. Zhonghua Bing Li Xue Za Zhi 2007;36: 474-9.
19. Bruin SC, Verwaal VJ, Vincent A, et al. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol 2010;17: 2330-40.
20. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27: 1089-103.
21. Turaga KK, Pappas SG, Gamblin TC. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol 2012;19: 1379-85.
22. Goldstein NS, Long A, Kuan SF, Hart J. Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl Immunohistochem Mol Morphol 2000;8: 183-8.